BR9801985C2 - Net composition applied in the treatment of peyronie's disease, collagenosis and fibrotic pathologies - Google Patents
Net composition applied in the treatment of peyronie's disease, collagenosis and fibrotic pathologiesInfo
- Publication number
- BR9801985C2 BR9801985C2 BR9801985A BR9801985A BR9801985C2 BR 9801985 C2 BR9801985 C2 BR 9801985C2 BR 9801985 A BR9801985 A BR 9801985A BR 9801985 A BR9801985 A BR 9801985A BR 9801985 C2 BR9801985 C2 BR 9801985C2
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- collagenosis
- peyronie
- composition applied
- treatment
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"COMPOSIçãO LIQUIDA APLICADA NA TERAPêUTICA DA DOENçA DE PEYRONIE, DE COLAGENOSES E PATOLOGIAS FIBRóTICAS". Certificado de Adição de Invenção do PI 9801985-6 depositado em 30 de abril de 1998. O presente certificado de adição de invenção refere-se a uma composição líquida aplicada na terapêutica da doença de Peyronie, de colagenoses e patologias fibróticas, tais como quelóides, cicatrizes hipertrófica, dermopaniculose vasculapática, doença de Dupuytren. A composição líquida do presente certificado de adição compreende em formulação: Papaína 0,020g; Hyaluronidase (300UI/g) 1,363mg Alfa Tocoferol 0,020g; Propileno glicol (0,923ml) 0,957g; Edetato de sódio 0,0002; Metilparaleno 0,001; Propilparaleno 0,0002; Potência 220 uni. INT/mg; e Densidade 1,037."LIQUID COMPOSITION APPLIED IN THERAPEUTICS OF PEYRONIE'S DISEASE, COLLAGENOSIS AND FIBROTIC PATHOLOGIES". Certificate of Addition of Invention of PI 9801985-6 deposited on April 30, 1998. This certificate of addition of invention refers to a liquid composition applied in the treatment of Peyronie's disease, collagenosis and fibrotic pathologies, such as keloids, hypertrophic scars, vasculapathic dermopaniculosis, Dupuytren's disease. The liquid composition of this certificate of addition comprises in formulation: Papain 0.020g; Hyaluronidase (300UI / g) 1,363mg Alpha Tocopherol 0.020g; Propylene glycol (0.923ml) 0.957g; 0.0002 sodium edetate; Methylparalene 0.001; Propylparalene 0.0002; Power 220 uni. INT / mg; and Density 1.037.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9801985A BR9801985B1 (en) | 1998-04-30 | 1998-04-30 | topical pharmaceutical composition and process for obtaining it. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9801985A BR9801985B1 (en) | 1998-04-30 | 1998-04-30 | topical pharmaceutical composition and process for obtaining it. |
Publications (6)
Publication Number | Publication Date |
---|---|
BR9801985A BR9801985A (en) | 2000-02-08 |
BR9801985C1 BR9801985C1 (en) | 2001-03-06 |
BR9801985C2 true BR9801985C2 (en) | 2001-03-20 |
BR9801985C3 BR9801985C3 (en) | 2001-05-08 |
BR9801985C4 BR9801985C4 (en) | 2001-06-12 |
BR9801985B1 BR9801985B1 (en) | 2011-12-27 |
Family
ID=4069742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9801985A BR9801985B1 (en) | 1998-04-30 | 1998-04-30 | topical pharmaceutical composition and process for obtaining it. |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR9801985B1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0000426B1 (en) * | 2000-01-28 | 2014-09-30 | Biolab Sanus Farmaceutica Ltda | PHARMACEUTICAL COMPOSITION |
BR0006719A (en) * | 2000-05-04 | 2001-09-25 | Cristiano Alberto Ribeiro Sant | Composition in the form of cream, gel and cream gel applied in the treatment of peyronie's disease, collagen and fibrotic pathologies based on vitamin-e, papain 2% and hyaluronidase |
WO2002074329A1 (en) * | 2001-03-19 | 2002-09-26 | Ribeiro Santana Cristiano Albe | Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process |
MXPA03009100A (en) | 2001-04-06 | 2004-02-17 | Cristiano Alberto Ribeiro Sant | Papaine containing pharmaceutical formulation resp. its use. |
WO2003015811A1 (en) * | 2001-08-17 | 2003-02-27 | Santana Cristiano Alberto Ribe | Process for obtaining a pharmaceutical composition |
ES2197018B1 (en) * | 2002-06-06 | 2005-10-01 | Especialidades Farmaceuticas Centrum Sa | NEW THERAPEUTIC USE OF POLYPODIUM EXTRACTS. |
US8465413B2 (en) | 2010-11-25 | 2013-06-18 | Coloplast A/S | Method of treating Peyronie's disease |
CN104069440A (en) * | 2014-07-15 | 2014-10-01 | 王福刚 | Traditional Chinese medicine for treating penis hardening disease |
-
1998
- 1998-04-30 BR BR9801985A patent/BR9801985B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR9801985B1 (en) | 2011-12-27 |
BR9801985C4 (en) | 2001-06-12 |
BR9801985A (en) | 2000-02-08 |
BR9801985C3 (en) | 2001-05-08 |
BR9801985C1 (en) | 2001-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR861241B (en) | Ultra mild skin cleansing composition | |
BR9815064A (en) | Detergent tablet | |
DK0839026T3 (en) | Micellar polyether block copolymer compositions for targeting biological agents | |
BR0206987A (en) | Catheter injectable depot compositions and uses thereof | |
BR0108173A (en) | Botulinum toxin pharmaceutical compositions | |
BR0003897A (en) | Additive to increase water resistance of cosmetic or dermatological formulations and their uses | |
BR9713866A (en) | Pharmaceutical composition | |
MY121360A (en) | Clear cleansing detergent systems. | |
TR200101793T2 (en) | Azabicycloalkanes as CCR5 modulators | |
IL162000A0 (en) | Injectable depot compositions and use thereof | |
PT1028707E (en) | CONTROLLED LIBERATION OPHTHALMIC FORMULATIONS CONTAINING SOLUABLE MEDICATIONS IN WATER | |
ES2012362B3 (en) | HAIR COSMETIC AGENT | |
BR9801985C2 (en) | Net composition applied in the treatment of peyronie's disease, collagenosis and fibrotic pathologies | |
PT799046E (en) | STABLE SOLUTIONS OF 2-CHLORO-2'-DEOXYADENOSIN | |
BR9809117A (en) | Composition of delayed release gel, process of producing the same, pharmaceutical formulation, and processes of treatment of an indication, a disease, and inflammation with a composition of prolonged release | |
BR0012696A (en) | Ophthalmic composition | |
DK0381617T3 (en) | Contact lens disinfectant and cleanser | |
NO953995D0 (en) | Ion polymers such as anthelmintics in animals | |
IL136101A (en) | Pharmaceutical compositions containing azelaic acid | |
BR0006719A (en) | Composition in the form of cream, gel and cream gel applied in the treatment of peyronie's disease, collagen and fibrotic pathologies based on vitamin-e, papain 2% and hyaluronidase | |
ZA974366B (en) | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations. | |
BR9705279A (en) | Use of an organosiloxane and cosmetic treatment process. | |
BR0101823A (en) | Pharmaceutical composition applied in the treatment of peyronie's disease, collagenosis and fibrotic pathologies based on vitamin-e, bromelain and hyaluronity | |
ES2141379T3 (en) | ANHYDROUS SURFACE MIXTURES. | |
GT199600070A (en) | COSMETIC GEL COMPOSITION HAVING REDUCED SKIN IRRITATION. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law |
Owner name: CERTIFICADO DE ADICAO DE INVENCAO |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: CLINICA DE ANDROLOGIA E UROLOGIA VERA CRUZ LTDA. ( Free format text: TRANSFERIDO DE: CRISTIANO ALBERTO RIBEIRO SANTANA |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] |
Free format text: FOURTH IMPROVED ADDITIONAL INVENTOR CERTIFICATE Free format text: THIRD IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: Free format text: SECOND IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: Free format text: IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A, 11A, 12A E 13A ANUIDADE(S). FOURTH ADDITIONAL INVENTOR CERTIFICATE Free format text: THIRD IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A 10A, 11A, 12A E 13A ANUIDADE(S). Free format text: SECOND IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A 11A, 12A E 13A ANUIDADE(S). Free format text: IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A 11A, 12A E 13A ANUIDADE(S). Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A 11A, 12A E 13A ANUIDADE(S). |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/12/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: THIRD IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. Free format text: SECOND IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. Free format text: IMPROVED ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 13A, 14A, 15A, 16A E 17A ANUIDADES. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |